Formulation and Evaluation of Prulifloxacin Sustained Release Matrix Tablets

  • V. Phani Deepthi Department of Pharmaceutics, JNTUA -Oil Technological and Pharmaceutical Research Institute, Anantapuramu, A.P, India
  • AMPAPURAM RAJESH PAVAN Department of Pharmaceutics, JNTUA -Oil Technological and Pharmaceutical Research Institute, Anantapuramu, A.P, India
  • G. Naresh Babu Department of Pharmaceutics, Balaji College of pharmacy, Ananthapuramu, AP, India.
  • K. Sreenivasulu Department of Pharmaceutics, Creative Educational Society’s College of Pharmacy, Kurnool, AP, India.
DOI https://doi.org/10.22270/jddt.v9i4.2974

Abstract

Prulifloxacin is a chemotherapeutic antibiotic of Fluor quinolone drug used to treat a various urinary tract infections. It has short half-life, makes the sustained release (SR) forms extremely advantageous. Sustained release tablets results in increased bioavailability. The purpose of the present study was to develop a sustain release matrix drug delivery system (SR) containing Prulifloxacin as a model drug by using various proportions of polymers such as HPMC E15, HPMC K15. The sustained release formulations of Prulifloxacin were prepared by direct compression method. Optimization of formulation was done by studying effect of drug to polymer ratio on drug release. FT-IR studies indicated absence of any interaction between Prulifloxacin, polymers (HPMC E15 and HPMC K15) and excipients. Ten formulations were prepared and Formulation F8 possesses good drug release property. The tablets were also evaluated for its hardness, friability and other In-vitro evaluation tests. All parameters complied with IP limits. Drug release was diffusion controlled and followed Zero order kinetics. Non-Fickian diffusion was the drug release mechanism for all the tablets formulated.


Keywords: Sustained drug delivery system, Prulifloxacin, HPMCE15, HPMCK15

Downloads

Download data is not yet available.

Author Biographies

V. Phani Deepthi, Department of Pharmaceutics, JNTUA -Oil Technological and Pharmaceutical Research Institute, Anantapuramu, A.P, India

Department of Pharmaceutics, JNTUA -Oil Technological and Pharmaceutical Research Institute, Anantapuramu, A.P, India

AMPAPURAM RAJESH PAVAN, Department of Pharmaceutics, JNTUA -Oil Technological and Pharmaceutical Research Institute, Anantapuramu, A.P, India

Department of Pharmaceutics, JNTUA -Oil Technological and Pharmaceutical Research Institute, Anantapuramu, A.P, India

G. Naresh Babu, Department of Pharmaceutics, Balaji College of pharmacy, Ananthapuramu, AP, India.

Department of Pharmaceutics, Balaji College of pharmacy, Ananthapuramu, AP, India.

K. Sreenivasulu, Department of Pharmaceutics, Creative Educational Society’s College of Pharmacy, Kurnool, AP, India.

Department of Pharmaceutics, Creative Educational Society’s College of Pharmacy, Kurnool, AP, India.

Statistics
128 Views | 153 Downloads
How to Cite
1.
Deepthi VP, PAVAN A, Babu GN, Sreenivasulu K. Formulation and Evaluation of Prulifloxacin Sustained Release Matrix Tablets. JDDT [Internet]. 15Jul.2019 [cited 6Mar.2021];9(4):72-1. Available from: http://www.jddtonline.info/index.php/jddt/article/view/2974
Issue
Vol 9 No 4 (2019): Volume 9, Issue 4, July-August 2019
Section
Research
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).